Litcius/Paper detail

AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome

Peng Li, Thomas A. White, Wei Xie, Wei Cui, Deniz Peker, Gang Zeng, Huan‐You Wang, Jennie Vagher, Sara Brown, Margaret S. Williams, Tibor Kovacsovics, Jay Patel

2021Leukemia58 citationsDOI

Topics & Concepts

GermlineMyeloidMedicineInternal medicineMyeloid leukemiaOncologyCytopeniaLeukemiaGermline mutationPathologyBiologyBone marrowMutationGeneticsGeneAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentHemoglobinopathies and Related Disorders
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome | Litcius